Hosted on MSN2mon
A potential pathway may guide new therapies for inflammatory bowel disease and other inflammatory diseases
BB1 treatment activates the toll-like receptor (TLR)-2/TLR-6 signaling pathway, leading to the activation of peroxisome proliferator-activated receptor γ (PPAR- γ).
Hosted on MSN25d
Researchers describe new molecular mechanisms linked to insulin resistance
This initiates a whole metabolic pathway with different steps that eventually ... The study assesses whether peroxisome proliferator-activated receptor (PPAR) β/δ can regulate InsRβ levels ...
Hoth Therapeutics Announces Positive Findings on GDNF's Potential as a Game-Changer in Obesity Treatment and Reduced Fatty Liver Disease
Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company, today announced preclinical findings that highlight the potential of Glial Cell Line-Derived Neurotrophic Factor ...